Skip to content
Norton & Elaine Sarnoff Center for Jewish Genetics Logo
  • Home
  • Get Screened
  • About Us
    • Board Members
    • Staff
  • Genetic Disorders
    • Types of Genetic Disorders
    • Jewish Genetic Disorder FAQs
    • Rabbinical Insights
  • Hereditary Cancer
    • BRCA Mutations
    • Lynch Syndrome
    • Assess Your Risk
    • Cancer FAQs
    • Cancer Resources
  • Resources
    • Preimplantation Genetic Testing
    • Family Health History
    • Teach Jewish Genetics
    • Community Resources
    • Educational Brochures
    • For Medical Professionals
    • Personal Stories
    • Blog
  • Get Involved
    • Events
    • Donate
Previous Next

Refsum Disease (PHYH-Related)

Refsum disease is a genetic condition caused by an enzyme in our cells, called the peroxisome, not breaking down a substance called phytanic acid. This leads to a buildup of this substance in the body.

The main symptom is vision loss known as retinitis pigmentosa (RP), causing issues like night blindness and tunnel vision, eventually leading to blindness. People with Refsum disease may experience various symptoms such as deafness, loss of the sense of smell (anosmia), lack of muscle control (ataxia), nerve degeneration leading to weakness or pain, dry scaly skin (ichthyosis), shortness of certain bones in the hands and feet, and heart rhythm problems. Not everyone has all these symptoms, and they can vary between individuals, even in the same family. Symptoms can start at different ages, ranging from age 2 to as late as the 40s or 50s, although most people have symptoms before turning 20. Currently, there’s no cure for the main cause of this condition. Treatment involves avoiding foods high in phytanic acid, like dairy products, beef, and certain seafood. While some symptoms may get better with treatment, it’s unclear if it helps with RP, deafness, or anosmia. In some cases, removing and replacing blood plasma may be necessary to lower phytanic acid levels in the blood.

Refsum disease is caused by pathogenic (disease-causing) variants in multiple genes and the test we offer covers the PHYH gene and exhibits autosomal recessive inheritance. This means that both parents must be carriers to have a 25% chance to have a child with the condition. The risk of being a carrier is based on a person’s ancestry or ethnic background.  

Other names for this condition are hereditary motor and sensory neuropathy type IV, heredopathia atactica polyneuritiformis, and phytanic acid storage disease.

Resources:  

DARE Foundation

Medline Plus

Revised November 2023

Scott Weissman2023-11-16T16:16:58+00:00November 16, 2023|

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTumblrPinterestVkXingEmail

About the Author: Scott Weissman

The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of the Jewish United Fund, and is supported in part by the Michael Reese Health Trust.

30 S Wells
Chicago, IL 60606
312-357-4718
jewishgenetics@juf.org

About
  • About Us
  • Genetic Disorders
  • Hereditary Cancer
  • Donate
Resources
  • Medical Professionals
  • Teach Jewish Genetics
  • Events

©2025 Norton & Elaine Sarnoff Center for Jewish Genetics

Page load link
Go to Top